| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 271.97B | 251.37B | 226.71B | 228.06B | 207.97B | 209.12B |
| Gross Profit | 126.17B | 116.54B | 104.78B | 106.80B | 101.09B | 87.75B |
| EBITDA | 77.54B | 74.55B | 66.11B | 67.84B | 64.45B | 55.97B |
| Net Income | 46.38B | 43.04B | 38.03B | 41.09B | 38.78B | 33.47B |
Balance Sheet | ||||||
| Total Assets | 340.14B | 330.76B | 323.46B | 298.71B | 279.69B | 265.51B |
| Cash, Cash Equivalents and Short-Term Investments | 34.04B | 27.45B | 22.74B | 29.65B | 34.66B | 32.38B |
| Total Debt | 40.95B | 40.47B | 40.98B | 27.29B | 22.71B | 22.67B |
| Total Liabilities | 94.60B | 94.58B | 92.56B | 77.19B | 71.68B | 64.95B |
| Stockholders Equity | 241.84B | 233.29B | 227.47B | 218.42B | 205.91B | 198.83B |
Cash Flow | ||||||
| Free Cash Flow | 46.41B | 43.01B | 12.70B | 15.05B | 29.10B | 30.40B |
| Operating Cash Flow | 63.66B | 59.18B | 33.70B | 35.23B | 41.95B | 39.94B |
| Investing Cash Flow | -19.60B | -17.61B | -18.74B | -19.64B | -12.39B | -12.85B |
| Financing Cash Flow | -39.75B | -35.65B | -22.10B | -25.03B | -27.87B | -25.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥894.13B | 19.32 | 19.69% | 3.15% | 10.06% | 18.03% | |
75 Outperform | ¥10.96T | 21.70 | 10.87% | 2.17% | 3.77% | 0.35% | |
68 Neutral | ¥844.69B | 24.65 | 4.79% | 4.21% | -1.21% | -27.21% | |
66 Neutral | ¥1.50T | 17.10 | 1.09% | 3.50% | -11.50% | 25.86% | |
65 Neutral | ¥962.49B | 9.88 | 8.79% | 2.68% | -1.64% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥558.68B | 77.07 | 1.08% | 3.37% | -1.94% | -84.08% |
Nissan Chemical reported consolidated results for the nine months to Dec. 31, 2025, with net sales rising 11.8% year on year to ¥195.4 billion and net income attributable to owners of the parent climbing 10.5% to ¥35.0 billion, while basic earnings per share reached ¥259.10. Total assets increased to ¥340.1 billion and the equity ratio improved to 71.1%, underscoring a solid financial position supported by higher comprehensive income.
The company kept its full-year outlook unchanged, forecasting fiscal 2025 net sales of ¥272.2 billion and net income of ¥44.0 billion, alongside an annual dividend of ¥180 per share, up from ¥174 the previous year. Steady profit growth, a higher projected year-end dividend, and continued share treasury activity signal confidence in earnings resilience and a commitment to shareholder returns, which may strengthen its standing among institutional investors and analysts.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6086.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical completed a board-authorized share repurchase program by acquiring 26,400 shares for ¥144.2 million between February 1 and February 3, 2026 on the Tokyo Stock Exchange. The buyback brings cumulative purchases under the May 2025 mandate to 1,815,100 shares for ¥8.999 billion, signaling continued capital allocation toward shareholder returns before the March 31, 2026 deadline.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6086.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation has continued its share buyback program, repurchasing 380,000 common shares on the Tokyo Stock Exchange between January 1 and January 31, 2026, at a total cost of approximately 2.06 billion yen. This transaction forms part of a broader board-approved repurchase authorization from May 2025 allowing buybacks of up to 2.5 million shares or 9 billion yen through March 31, 2026; as of January 31, 2026, the company has acquired 1,788,700 shares for about 8.86 billion yen, indicating the program is close to completion and reflecting ongoing efforts to enhance shareholder returns and optimize capital structure.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6086.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation has continued its share repurchase program, buying 340,000 common shares on the Tokyo Stock Exchange between December 1 and December 31, 2025, at a total cost of approximately 1.8 billion yen. This transaction forms part of a broader board-approved buyback plan, under which the company is authorized to repurchase up to 2.5 million shares or 9 billion yen through March 31, 2026; as of December 31, 2025, it had cumulatively acquired about 1.41 million shares for roughly 6.8 billion yen, signaling an ongoing effort to enhance capital efficiency and return value to shareholders.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6081.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.